Pursuing integration of performance measures into electronic medical records: beta-adrenergic receptor antagonist medications

Objective: Electronic medical records seldom integrate performance indicators into daily operations. Assessing quality indicators traditionally requires resource intensive chart reviews of small samples. We sought to use an electronic medical record to assess use of β-adrenergic antagonist medications (β-blockers) following myocardial infarction, to compare a standardized manual assessment with assessment using electronic medical records, and to discuss potential for future integration of performance indicators into electronic records. Design: Cross-sectional data analysis. Setting: An urban academic medical center. Participants: US Medicare beneficiaries 65 years of age or older, admitted to hospital with myocardial infarction between 1995 and 1999. Measurements and main results: Manual chart review was compared with a computer driven assessment of electronic records. Administration of β-blockers and cases excluded from use of β-blockers were measured, based on Medicare criteria. Among 4490 older adults, 391 (4%) of 9018 hospital admissions contained codes for myocardial infarction. In 323 (83%) of the 391 hospital admissions, criteria for excluding β-blockers were met; 235 (60%) were excluded due to heart failure. Of 68 hospital admissions for myocardial infarction that did not meet exclusion criteria, physicians prescribed β-blockers in 49 (72%) on admission and 42 (62%) at discharge. Compared with manual chart review, electronic review had a sensitivity of 83–100% and led to fewer false negative findings. Conclusions: An electronic medical records system can be used instead of chart review to measure use of β-blockers after myocardial infarction. This should lead to integration of real time automated performance measurement into electronic medical records.

[1]  H. Krumholz.  Key challenges in measuring quality of care: what needs to be done? , 2001, The American journal of medicine.

[2]  B J McNeil,et al.  Pitfalls in assessing the quality of care for patients with cardiovascular disease. , 2001, American Journal of Medicine.

[3]  Moskowitz,et al.  beta-Blockers in congestive heart failure. , 1999 .

[4]  R. Matz.  Use of critical pathways to improve the care of patients with acute myocardial infarction. , 2000, The American journal of medicine.

[5]  H. Krumholz,et al.  Beta-blockers after myocardial infarction--for few patients, or many? , 1998, The New England journal of medicine.

[6]  H. Krumholz,et al.  Early beta-blocker therapy for acute myocardial infarction in elderly patients. , 1999, Annals of internal medicine.

[7]  C. McDonald,et al.  Reminders to physicians from an introspective computer medical record. A two-year randomized trial. , 1984, Annals of internal medicine.

[8]  C M Ashton,et al.  International Classification of Diseases, 9th Revision, Clinical Modification codes in discharge abstracts are poor measures of complication occurrence in medical inpatients. , 1997, Medical care.

[9]  C. McDonald,et al.  Computerized display of past test results. Effect on outpatient testing. , 1987, Annals of internal medicine.

[10]  C J McDonald,et al.  The Regenstrief medical records. , 1988, M.D. computing : computers in medical practice.

[11]  R. Califf,et al.  1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[12]  J. Goodwin,et al.  Beta blocker use in the treatment of community hospital patients discharged after myocardial infarction , 1994, Journal of General Internal Medicine.

[13]  K Sheikh,et al.  Urban-rural differences in the quality of care for medicare patients with acute myocardial infarction. , 2001, Archives of internal medicine.

[14]  Alastair Baker,et al.  Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.

[15]  S. Yusuf,et al.  Beta-blocker therapy for congestive heart failure: a systemic overview and critical appraisal of the published trials. , 1998, The Canadian journal of cardiology.

[16]  R H Brook,et al.  Watching the doctor-watchers. How well do peer review organization methods detect hospital care quality problems? , 1992, JAMA.

[17]  L I Iezzoni,et al.  Coding of acute myocardial infarction. Clinical and policy implications. , 1988, Annals of internal medicine.

[18]  H. Krumholz,et al.  β-Blocker Therapy in Heart Failure: Scientific Review , 2002 .

[19]  J Genest,et al.  [The quality of medical care]. , 1971, L'union medicale du Canada.

[20]  H. Krumholz,et al.  National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. , 1998, JAMA.

[21]  L. Goldman,et al.  Health and economic benefits of increased beta-blocker use following myocardial infarction. , 2000, JAMA.

[22]  Richard P. Lewis,et al.  ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[23]  J. Newhouse.  How much should Medicare pay for drugs? , 2004, Health affairs.

[24]  H. Krumholz,et al.  Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. , 1995, JAMA.

[25]  S. Goldstein.  Benefits of β-Blocker Therapy for Heart Failure: Weighing the Evidence , 2002 .

[26]  H. Krumholz,et al.  beta-Blocker therapy in heart failure: scientific review. , 2002, JAMA.

[27]  J. Marc Overhage,et al.  Research Paper: A Randomized Trial of "Corollary Orders" to Prevent Errors of Omission , 1997, J. Am. Medical Informatics Assoc..

[28]  S. Goldstein.  Benefits of beta-blocker therapy for heart failure: weighing the evidence. , 2002, Archives of internal medicine.

[29]  M. Marshall,et al.  Rewarding results: using financial incentives to improve quality , 2003, Quality & safety in health care.

[30]  B. B. Fleming,et al.  Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels. , 2000, JAMA.

[31]  Sheila Leatherman,et al.  The business case for quality: case studies and an analysis. , 2003, Health affairs.

[32]  Robert Parrish,et al.  Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. , 2002, JAMA.

[33]  J. Marc Overhage,et al.  The regenstrief medical record system 2000: Expanding the breadth and depth of a community wide EMR , 2000, AMIA.

[34]  B. Gersh,et al.  Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly. , 2000, Circulation.

[35]  Gerard F Anderson,et al.  How does the quality of care compare in five countries? , 2004, Health affairs.

[36]  Michael Weiner,et al.  Using Information Technology To Improve the Health Care of Older Adults , 2003, Annals of Internal Medicine.

[37]  H. Krumholz,et al.  Physician characteristics and the initiation of beta-adrenergic blocking agent therapy after acute myocardial infarction in a managed care population. , 2001, The American journal of managed care.

[38]  Donald Berwick,et al.  Developing and Testing Changes in Delivery of Care , 1998, Annals of Internal Medicine.

[39]  S. Gottlieb,et al.  Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. , 1998, The New England journal of medicine.

[40]  P. Underwood,et al.  Secondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issues , 2002, Quality & safety in health care.

[41]  D. Labarthe,et al.  An assessment of the validity of ICD Code 410 to identify hospital admissions for myocardial infarction: The Corpus Christi Heart Project. , 1996, International journal of epidemiology.

[42]  C. McDonald,et al.  A computerized reminder system to increase the use of preventive care for hospitalized patients. , 2001, The New England journal of medicine.

[43]  E. Ellerbeck,et al.  Optimizing beta-blocker use after myocardial infarction. , 2000, American family physician.

[44]  H. Krumholz,et al.  Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction? , 2000, Archives of internal medicine.

[45]  Thomas H. Lee,et al.  Paying physicians for high-quality care. , 2004, The New England journal of medicine.

[46]  et al.,et al.  The Regenstrief Medical Record System: a quarter century experience , 1999, Int. J. Medical Informatics.

[47]  L. Goldman,et al.  Health and Economic Benefits of Increased β-Blocker Use Following Myocardial Infarction , 2000 .

[48]  C. Patterson,et al.  Joint Commission on Accreditation of Healthcare Organizations. , 1995 .

[49]  W M Tierney,et al.  Effectiveness of Computer-Generated Reminders for Increasing Discussions about Advance Directives and Completion of Advance Directive Forms , 1998, Annals of Internal Medicine.

[50]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[51]  C. McDonald.  Protocol-based computer reminders, the quality of care and the non-perfectability of man. , 1976, The New England journal of medicine.

[52]  C. Brotons,et al.  Prophylactic treatment after myocardial infarction in primary care: how far can we go? , 2003, Family practice.

[53]  Clement J. McDonald,et al.  The Regenstrief Medical Record System , 1977 .

[54]  H. Krumholz,et al.  Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. , 2001, Journal of the American College of Cardiology.

[55]  H. Krumholz,et al.  Early -Blocker Therapy for Acute Myocardial Infarction in Elderly Patients , 1999, Annals of Internal Medicine.

[56]  H. Krumholz,et al.  β-Blockers in Heart Failure: Clinical Applications , 2002 .

[57]  L. Iezzoni,et al.  Using Administrative Diagnostic Data to Assess the Quality of Hospital Care: Pitfalls and Potential of ICD-9-CM , 1990, International Journal of Technology Assessment in Health Care.

[58]  Lawrence Joseph,et al.  β-Blockers in Congestive Heart Failure: A Bayesian Meta-Analysis , 2001 .

[59]  C J McDonald,et al.  Delayed Feedback of Physician Performance Versus Immediate Reminders to Perform Preventive Care: Effects on Physician Compliance , 1986, Medical care.

[60]  H. Krumholz,et al.  Are β-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction? , 2000 .